•
Mar 31, 2022

Immuneering Q1 2022 Earnings Report

Total Revenue
$184K
Previous year: $748K
-75.4%
EPS
-$0.49
Previous year: -$1.26
-61.1%
Gross Profit
$92.9K
Previous year: $339K
-72.6%
Cash and Equivalents
$75.2M
Previous year: $30.9M
+143.1%
Free Cash Flow
-$12.4M
Previous year: -$6.16M
+101.4%
Total Assets
$152M

Immuneering

Immuneering